Winston Churchill Net Worth

The estimated Net Worth of Winston J Churchill is at least $6.9 Milion dollars as of 27 August 2024. Mr. Churchill owns over 20,000 units of Recro Pharma Inc stock worth over $83,330 and over the last 21 years he sold REPH stock worth over $6,373,648. In addition, he makes $439,838 as Independent Director at Recro Pharma Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Churchill REPH stock SEC Form 4 insiders trading

Winston has made over 84 trades of the Recro Pharma Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of REPH stock worth $234,200 on 27 August 2024.

The largest trade he's ever made was buying 100,000 units of Recro Pharma Inc stock on 31 August 2021 worth over $63,000. On average, Winston trades about 7,462 units every 46 days since 2003. As of 27 August 2024 he still owns at least 39,871 units of Recro Pharma Inc stock.

You can see the complete history of Mr. Churchill stock trades at the bottom of the page.

Winston Churchill biography

Winston J. Churchill Jr. J.D. serves as Independent Director of the Company. Mr. Churchill has been a director of the corporate general partner of the common general partner of SCP Vitalife Partners II, L.P. and SCP Vitalife Partners (Israel) II, L.P., collectively referred to herein as SCP Vitalife, which beneficially owns 12% of our outstanding stock as of March 19, 2020. He has also served as a managing member of SCP Vitalife Management Company, LLC, which by contract provides certain management services to the common general partner of SCP Vitalife. Mr. Churchill has also served since 1993 as the President of CIP Capital Management, Inc., the general partner of CIP Capital, L.P., an Small Business Administration-licensed private equity fund. Prior to that, Mr. Churchill was a managing partner of Bradford Associates, which managed private equity funds on behalf of Bessemer Securities Corporation and Bessemer Trust Company. From 1967 to 1983, Mr. Churchill practiced law at the Philadelphia firm of Saul Ewing, LLP, where he served as Chairman of the Banking and Financial Institutions Department, Chairman of the Finance Committee and was a member of the Executive Committee. Mr. Churchill is a director of Innovative Solutions and Support, Inc., Amkor Technology, Inc., Baudax Bio and various SCP Vitalife portfolio companies and he previously served as a director of Griffin Industrial Realty from April 1997 until May 2016.

What is the salary of Winston Churchill?

As the Independent Director of Recro Pharma Inc, the total compensation of Winston Churchill at Recro Pharma Inc is $439,838. There are 4 executives at Recro Pharma Inc getting paid more, with Geraldine Henwood having the highest compensation of $4,622,980.

How old is Winston Churchill?

Winston Churchill is 79, he's been the Independent Director of Recro Pharma Inc since 2008. There are no older and 9 younger executives at Recro Pharma Inc.

What's Winston Churchill's mailing address?

Winston's mailing address filed with the SEC is 500 SE MIZNER BLVD., APT 305A, BOCA RATON, FL, 33432-6083.

Insiders trading at Recro Pharma Inc

Over the last 11 years, insiders at Recro Pharma Inc have traded over $25,533,136 worth of Recro Pharma Inc stock and bought 3,055,820 units worth $22,429,197 . The most active insiders traders include Healthcare Master Fund Ltd ..., Investment Company, Inc. Awm a James E Deerfield Mgmt L.P..... On average, Recro Pharma Inc executives and independent directors trade stock every 31 days with the average trade being worth of $151,953. The most recent stock trade was executed by J David Jr Enloe on 15 March 2022, trading 512 units of REPH stock currently worth $1,004.

What does Recro Pharma Inc do?

Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.

Complete history of Mr. Churchill stock trades at AMKOR Technology, Griffin Industrial Realty Inc, Innovative Solutions And Support Inc, Recro Pharma Inc a Baudax Bio Inc

Recro Pharma Inc executives and stock owners

Recro Pharma Inc executives and other stock owners filed with the SEC include:

• Geraldine Henwood,
  President, Chief Executive Officer, Director
• Ryan Lake,
  Chief Financial Officer
• William Ashton,
  Independent Director
• Wayne Weisman,
  Independent Chairman of the Board
• Winston Churchill,
  Independent Director
• Michael Berelowitz,
  Independent Director
• Ryan D. Lake,
  Chief Financial Officer
• Bryan Reasons,
  Independent Director
• J. David Enloe Jr.,
  Pres, CEO & Director
• Argot Partners,
  IR Contact Officer
• Tim Bourque,
  VP of Operations & Site Head of San Diego
• David Smithwick B.S.,
  VP of Operations & Site Head of Gainesville
• Richard Sidwell Ph.D.,
  VP & Chief Scientific Officer
• Marshall Rizzo M.B.A.,
  Sr. VP & GM
• Randall J. Mack,
  Sr. VP of Devel.
• Erica Raether M.A.,
  VP of People, Culture & ESG
• William Hirschman,
  VP of Sales & Marketing
• Matthew McKendry,
  Director of Accounting
• Laura L. Parks,
  Director
• Karen Flynn,
  Director
• Vitalife Partners Ii Lp Scp,
  10% owner
• Donna Nichols,
  CAO/Controller
• Stewart Mc Callum,
  Chief Medical Officer
• Randall Mack,
  Senior VP, Development
• Fred Graff,
  Chief Commercial Officer
• Capital Management, Llc Sto...,
  10% owner
• James E Deerfield Mgmt L.P....,
  
• Vitalife Partners (Israel) ...,
  10% owner
• Alfred Altomari,
  Director
• Healthcare Master Fund Ltd ...,
  
• Diane Myers,
  Senior VP-Reg./Quality
• Jyrki Mattila,
  Executive VP, Business Dev.
• Michael Celano,
  Chief Financial Officer
• Arnaud Ajdler,
  Director
• Abraham Ludomirski,
  Director
• Charles Garner,
  CFO and Chief Business Officer
• J David Jr Enloe,
  Chief Executive Officer
• James Charles Miller,
  Director
• Investment Company, Inc. Awm,
  10% owner